Title:
TAQMAN PROBE REAL-TIME FLUORESCENT PCR METHOD FOR DETECTING RS6313 SITE OF HTR2A GENE AND PRIMER AND PROBE COMBINATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/082358
Kind Code:
A1
Abstract:
The present invention belongs to the field of gene diagnosis. Disclosed in the present invention are a TaqMan probe real-time fluorescent PCR method for detecting rs6313 site (HTR2A, 102C>T) of HTR2A gene and a primer and probe combination thereof.
Inventors:
WANG HUIJUAN (CN)
KANG XING (CN)
HAN MIN (CN)
KANG XING (CN)
HAN MIN (CN)
Application Number:
PCT/CN2020/084692
Publication Date:
May 06, 2021
Filing Date:
April 14, 2020
Export Citation:
Assignee:
SHAANXI LIFEGEN CO LTD (CN)
International Classes:
C12Q1/6858; C12N15/11
Domestic Patent References:
| WO2006121423A2 | 2006-11-16 | |||
| WO2008076449A2 | 2008-06-26 |
Foreign References:
| CN110643689A | 2020-01-03 | |||
| EP3037549A1 | 2016-06-29 | |||
| US20090042194A1 | 2009-02-12 | |||
| US20080233657A1 | 2008-09-25 | |||
| US20030157507A1 | 2003-08-21 | |||
| CN109929927A | 2019-06-25 | |||
| US20150148336A1 | 2015-05-28 |
Other References:
SUN XUE-LI, LI XI-RONG, HE LIN, HE GUANG, YU TAO, DONG ZAI-QUAN: "5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients", NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol. Volume 12, pages 1623 - 1629, XP055808952, DOI: 10.2147/NDT.S93562
Attorney, Agent or Firm:
XI'AN ZHIBANG PATENT&TRADEMARK AGENT CO., LTD. (CN)
Download PDF: